Literature DB >> 17848548

Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Ayse Hacisalihoglu1, Peter Panizzi, Paul E Bock, Rodney M Camire, Sriram Krishnaswamy.   

Abstract

The preferred pathway for prothrombin activation by prothrombinase involves initial cleavage at Arg(320) to produce meizothrombin, which is then cleaved at Arg(271) to liberate thrombin. Exosite binding drives substrate affinity and is independent of the bond being cleaved. The pathway for cleavage is determined by large differences in V(max) for cleavage at the two sites within intact prothrombin. By fluorescence binding studies in the absence of catalysis, we have assessed the ability of the individual cleavage sites to engage the active site of Xa within prothrombinase at equilibrium. Using a panel of recombinant cleavage site mutants, we show that in intact prothrombin, the Arg(320) site effectively engages the active site in a 1:1 interaction between substrate and enzyme. In contrast, the Arg(271) site binds to the active site poorly in an interaction that is approximately 600-fold weaker. Perceived substrate affinity is independent of active site engagement by either cleavage site. We further show that prior cleavage at the 320 site or the stabilization of the uncleaved zymogen in a proteinase-like state facilitates efficient docking of Arg(271) at the active site of prothrombinase. Therefore, we establish direct relationships between docking of either cleavage site at the active site of the catalyst, the V(max) for cleavage at that site, substrate conformation, and the resulting pathway for prothrombin cleavage. Exosite tethering of the substrate in either the zymogen or proteinase conformation dictates which cleavage site can engage the active site of the catalyst and enforces the sequential cleavage of prothrombin by prothrombinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848548      PMCID: PMC2292459          DOI: 10.1074/jbc.M706529200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Binding energy, specificity, and enzymic catalysis: the circe effect.

Authors:  W P Jencks
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0.

Authors:  W Bode; P Schwager
Journal:  J Mol Biol       Date:  1975-11-15       Impact factor: 5.469

3.  Coagulant protein of Russell's viper venom.

Authors:  B C Furie; B Furie
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

4.  Activation of human factor X (Stuart factor) by a protease from Russell's viper venom.

Authors:  R G Di Scipio; M A Hermodson; E W Davie
Journal:  Biochemistry       Date:  1977-11-29       Impact factor: 3.162

5.  The association of anhydrotrypsin with the pancreatic trypsin inhibitors.

Authors:  J P Vincent; M Peron-Renner; J Pudles; M Lazdunski
Journal:  Biochemistry       Date:  1974-09-24       Impact factor: 3.162

6.  Mechanism of action of naturally occurring proteinase inhibitors. Studies with anhydrotrypsin and anhydrochymotrypsin purified by affinity chromatography.

Authors:  H Ako; R J Foster; C A Ryan
Journal:  Biochemistry       Date:  1974-01-01       Impact factor: 3.162

Review 7.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

9.  Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.

Authors:  D S Boskovic; S Krishnaswamy
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

10.  Removal of B-domain sequences from factor V rather than specific proteolysis underlies the mechanism by which cofactor function is realized.

Authors:  Raffaella Toso; Rodney M Camire
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

View more
  11 in total

Review 1.  The transition of prothrombin to thrombin.

Authors:  S Krishnaswamy
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

2.  A revisit to the one form kinetic model of prothrombinase.

Authors:  Chang Jun Lee; Sangwook Wu; Changsun Eun; Lee G Pedersen
Journal:  Biophys Chem       Date:  2010-03-25       Impact factor: 2.352

3.  Inhibition of thrombin formation by active site mutated (S360A) activated protein C.

Authors:  Gerry A F Nicolaes; Paul E Bock; Kenneth Segers; Karin C A A Wildhagen; Björn Dahlbäck; Jan Rosing
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

4.  Macromolecular assembly-driven processing of the 2/3 cleavage site in the alphavirus replicase polyprotein.

Authors:  Aleksei Lulla; Valeria Lulla; Andres Merits
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

5.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

6.  Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.

Authors:  Heather K Kroh; Peter Panizzi; Svetlana Tchaikovski; T Regan Baird; Nancy Wei; Sriram Krishnaswamy; Guido Tans; Jan Rosing; Bruce Furie; Barbara C Furie; Paul E Bock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

7.  Activation of factor XI by products of prothrombin activation.

Authors:  Anton Matafonov; Suryakala Sarilla; Mao-fu Sun; John P Sheehan; Vladimir Serebrov; Ingrid M Verhamme; David Gailani
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

8.  Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling.

Authors:  Hung-Ju Hsu; Keng-Chang Tsai; Yi-Kun Sun; Hung-Ju Chang; Yi-Jen Huang; Hui-Ming Yu; Chun-Hung Lin; Shi-Shan Mao; An-Suei Yang
Journal:  J Biol Chem       Date:  2008-02-22       Impact factor: 5.157

9.  Regulated cleavage of prothrombin by prothrombinase: repositioning a cleavage site reveals the unique kinetic behavior of the action of prothrombinase on its compound substrate.

Authors:  Harlan N Bradford; Joseph A Micucci; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

10.  Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.

Authors:  Harlan N Bradford; Steven J Orcutt; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.